| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
64,673 |
59,286 |
$2.51M |
| 62323 |
|
2,857 |
2,833 |
$669K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
15,851 |
3,156 |
$492K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,877 |
2,867 |
$233K |
| 77002 |
|
6,946 |
2,945 |
$229K |
| 99223 |
Prolong inpt eval add15 m |
3,000 |
2,868 |
$207K |
| 20610 |
|
4,538 |
2,519 |
$150K |
| 20553 |
|
2,893 |
2,813 |
$141K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
9,755 |
8,094 |
$138K |
| 62321 |
|
602 |
600 |
$133K |
| 77003 |
|
3,032 |
2,929 |
$120K |
| 76942 |
|
2,714 |
2,310 |
$82K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
4,198 |
4,077 |
$75K |
| 95991 |
|
1,120 |
949 |
$59K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
1,227 |
547 |
$43K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,579 |
1,501 |
$38K |
| 64483 |
|
517 |
510 |
$34K |
| 64493 |
|
227 |
149 |
$30K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
122 |
117 |
$25K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,693 |
1,579 |
$19K |
| 64494 |
|
172 |
125 |
$10K |
| 64495 |
|
147 |
110 |
$9K |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
471 |
450 |
$5K |
| 64484 |
|
38 |
38 |
$4K |
| 62368 |
|
43 |
24 |
$712.97 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
566 |
249 |
$364.31 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12 |
12 |
$77.22 |